These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9015369)

  • 1. Regulation of C1-inhibitor function by binding to type IV collagen and heparin.
    Patston PA; Schapira M
    Biochem Biophys Res Commun; 1997 Jan; 230(3):597-601. PubMed ID: 9015369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of the recombinant human C1 inhibitor serpin domain: insights into heparin binding.
    Rossi V; Bally I; Ancelet S; Xu Y; Frémeaux-Bacchi V; Vivès RR; Sadir R; Thielens N; Arlaud GJ
    J Immunol; 2010 May; 184(9):4982-9. PubMed ID: 20351192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-stimulated modification of C1-inhibitor by subcomponent C1s of human complement.
    Weiss V; Engel J
    Hoppe Seylers Z Physiol Chem; 1983 Mar; 364(3):295-301. PubMed ID: 6602754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin binding and augmentation of C1 inhibitor activity.
    Caldwell EE; Andreasen AM; Blietz MA; Serrahn JN; VanderNoot V; Park Y; Yu G; Linhardt RJ; Weiler JM
    Arch Biochem Biophys; 1999 Jan; 361(2):215-22. PubMed ID: 9882449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
    van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
    J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the proteolytic activity of the complement protease C1s by polyanions: implications for polyanion-mediated acceleration of interaction between C1s and SERPING1.
    Murray-Rust TA; Kerr FK; Thomas AR; Wu T; Yongqing T; Ong PC; Quinsey NS; Whisstock JC; Wagenaar-Bos IC; Freeman C; Pike RN
    Biochem J; 2009 Aug; 422(2):295-303. PubMed ID: 19522701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serpins and the complement system.
    Beinrohr L; Murray-Rust TA; Dyksterhuis L; Závodszky P; Gál P; Pike RN; Wijeyewickrema LC
    Methods Enzymol; 2011; 499():55-75. PubMed ID: 21683249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of heparin and glucose on structural conformation of human alpha1 antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor.
    Finotti P; de Laureto PP
    Arch Biochem Biophys; 1997 Nov; 347(1):19-29. PubMed ID: 9344460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-independent C1 activation by E. coli.
    Tenner AJ; Ziccardi RJ; Cooper NR
    J Immunol; 1984 Aug; 133(2):886-91. PubMed ID: 6376630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The balance between inhibition and substrate-type reactions of recombinant C1 inhibitor P5/P3 variants.
    Eldering E; Huijbregts CC; Nuijens JH; Hack CE
    Behring Inst Mitt; 1993 Dec; (93):125-30. PubMed ID: 8172559
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of active human C1 inhibitor serpin domain in Escherichia coli.
    Lamark T; Ingebrigtsen M; Bjørnstad C; Melkko T; Mollnes TE; Nielsen EW
    Protein Expr Purif; 2001 Jul; 22(2):349-58. PubMed ID: 11437612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor.
    Wijeyewickrema LC; Lameignere E; Hor L; Duncan RC; Shiba T; Travers RJ; Kapopara PR; Lei V; Smith SA; Kim H; Morrissey JH; Pike RN; Conway EM
    Blood; 2016 Sep; 128(13):1766-76. PubMed ID: 27338096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of the serpin domain of C1 inhibitor.
    Coutinho M; Aulak KS; Davis AE
    J Immunol; 1994 Oct; 153(8):3648-54. PubMed ID: 7930585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of SPAAT, the 44-residue C-terminal peptide of alpha 1-antitrypsin, to proteins of the extracellular matrix.
    Niemann MA; Baggott JE; Miller EJ
    J Cell Biochem; 1997 Sep; 66(3):346-57. PubMed ID: 9257191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate.
    Patston PA; Gettins P; Beechem J; Schapira M
    Biochemistry; 1991 Sep; 30(36):8876-82. PubMed ID: 1888745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
    Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
    Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous activation of reconstituted and serum C1 and the role of C1-inhibitor.
    Schumaker VN; Tseng Y; Poon PH; Bianchino AC; Zavodszky P
    Behring Inst Mitt; 1989 Jul; (84):102-10. PubMed ID: 2803179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activator-bound C1 is less susceptible to inactivation by C1 inhibition than is fluid-phase C1.
    Tenner AJ; Frank MM
    J Immunol; 1986 Jul; 137(2):625-30. PubMed ID: 3722818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of host extracellular matrix proteins to Mycoplasma fermentans and its effect on adherence to, and invasion of HeLa cells.
    Yavlovich A; Rottem S
    FEMS Microbiol Lett; 2007 Jan; 266(2):158-62. PubMed ID: 17233726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the distal hinge region of C1-inhibitor in the regulation of C1s activity.
    He S; Yang JC; Tsang S; Sim RB; Whaley K
    FEBS Lett; 1997 Aug; 412(3):506-10. PubMed ID: 9276455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.